A new human acute monocytic leukemia cell line SHI-1 with t(6;11)(q27;q23), p53 gene alterations and high tumorigenicity in nude mice

Haematologica

Volumn 90, Issue 6, 2005, Pages 766-775

  Chen, Suning ^a   Xue, Yongquan ^a   Zhang, Xueguang ^b   Wu, Yafang ^a   Pan, Jinlan ^a   Wang, Yong ^a   Ceng, Jiannong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Acute monocytic leukemia; Leukemia cell line; Nude mice; p53 gene; Tumorigenicity

Indexed keywords

CELL DNA; MIXED LINEAGE LEUKEMIA PROTEIN; PROTEIN P53;

ACUTE MONOCYTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CASE REPORT; CELL STRAIN SHI 1; CHROMOSOME 17P; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION 11; CONTROLLED STUDY; CYTOGENETICS; DNA FINGERPRINTING; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; KARYOTYPING; LEUKEMIA CELL LINE; LEUKEMIA RELAPSE; LIQUID CULTURE; MALE; MOUSE; NONHUMAN; NUDE MOUSE; POINT MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHORT TANDEM REPEAT; ZYMOGRAPHY;

ADULT; ANIMALS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL LINEAGE; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 6; GENES, P53; HUMANS; LEUKEMIA, MONOCYTIC, ACUTE; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; POINT MUTATION; RECURRENCE; TRANSLOCATION, GENETIC;

EID: 21244497623     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Drexler HG, Quentmeier H, MacLeod RAF. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations. Leukemia 2004; 18:227-32.
2. Drexler HG, MacLeod RAF. Leukemia-lymphoma cell lines as model systems for hematopoietic research. Ann Med 2003;35:404-12.
3. Pulvertaft RJV. Cytology of Burkitt's tumour (African lymphoma). Lancet 1964;1:238-40.
4. Drexler HG, editor. The Leukemia-lymphoma cell line factsbook. Academic press, San Diego, USA. 2000.
5. Drexler HG, Matsuo Y. Guidelines for the characterization and publication of human malignant hematopoietic cell lines. Leukemia 1999;13:835-42.
6. Bennet JM, Catovsky D, Daniel MT, Handrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the acute leukemias. The French-American-British (FAB) cooperative Group. Br J Haematol 1976;33:451-8.
7. Takeuchi S, Sugito S, Uemura Y, Miyagi T, Kubonishi I, Taguchi H, et al. Acute megakaryoblastic leukemia: establishment of a new cell line (MKPL-1) in vitro and in vivo. Leukemia 1992;6:588-94.
8. Anderson WA, Trantalis J, Kang YH. Ultrastructural localization of endogenous mammary gland peroxidase during lactogenesis in the rat results tannic acid-formaldehyde-glutalaldehyde fixation. J Histochem Cytochem 1975; 23:295-302.
9. Mitterbauer G, Zimmer C, Fonatsch C, Haas O, Thalhammer-Scherrer R, Schwarzinger I, et al. Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukemia by RT-PCR. Leukemia 1999; 13:1519-24.
10. Pallisgaard N, Hokland P, Riishoj DC, Pedersen B, Jorgensen P. Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood 1998;92:574-88.
11. Nollet F, Billiet J, Selleslag D, Criel A. Standardisation of multiplex fluorescent short tandem repeat analysis for chimerism testing. Bone Marrow Transplantation 2001;28:511-8.
12. Janowska-Wieczorek A, Marquez LA, Matsuzaki A, Hashmi HR, Larratt LM, Boshkov LM, et al. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells. Br J Haematol 1999;105:402-11.
13. Huret JL, Dessen P, Bemheim A. The Groupe Frangsis de Cytogénétique Oncologique: an Atlas on chromosomes in Hematological Malignancies. Example: 11q23 and MLL partners. Leukemia 2001;15:987-99.
14. Yu BD, Hess JL, Horning SE, Brown GA, Korsmeyer SJ. Altered HOX expression and segmental identity in MLL-mutant mice. Nature 1995;378: 505-8.
15. Martineau M, Berger R, Lillington DM. The t(6;11)(q27;q23) translocation in acute leukemia: a laboratory and clinical studies of 30 cases. Leukemia 1998; 12:788-91.
16. Heim S, Mitelman F: Cytogenetics of acute non lymphocytic leukemia, in cancer cytogenetics. New York, NY, Liss; 1987. p. 965.
17. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989;342:705-8.
18. Mhawech P, Saleem A. Myelodysplastic syndrome: review of the cytogenetic and molecular data. Crit Rev Oncol/Hematol 2001;40:229-38.
19. Smith ML, Fornace AJ Jr. Genomic instability and the role of p53 mutations in cancer cells. Curr Opin Oncol 1995;7:69-75.
20. Fenaux P, Jonrenaux P, Quiquandon I, Lai JL, Pignon JM, Loucheux-Lefebvre MH, et al. P53 gene mutation in acute myeloid leukemia with 17p monosomy. Blood 1991;78:1652-7.
21. th edition. Brunschweig: Germany; DSMZ. 2001.
22. Tanabe S, Zelegnikte NJ, Kobuyashi H, Vignon C, Espinosa R 3rd, LeBeau MM, et al. Analysis of the t(6;11)(q27;q23) in leukemia shows a consistent breakpoint in AF6 in three patients and in the ml-2 cell line. Genes chromosomes Cancer 1996;15:206-16.
23. Kakuda H, Sato T, Hayashi Y, Enomoto Y, Takayama J, Ohira M, et al. A novel human leukemia cell line, CTS, has a t(6;11) chromosomal translocation and characteristics of pluripotent stem cells. Br J Haematol 1996;95:306-18.
24. Quentmeier H, Reinharat J, Zaborski M. MLL partial tandem duplications in acute leukemia cell lines. Leukemia 2003;17:980-981.